Company / Current Liabilities
Korro Bio, Inc. Current Liabilities History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities
$11.9M
FY2025
5-year range
$11.4M / $26.6M
FY2021-FY2025
Trend
-20.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $21M to $12M over the past 3 years.
Based on SEC 10-K filings.
$12M in FY2025 with a 5-year CAGR of -14.8%.
Improved from $21M to $12M over the past 3 years.
Current Liabilities over time
Growth rates
- 3-Year CAGR
- -17.2%
- 5-Year CAGR
- -14.8%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -14.8%, indicating a declining trend.
- In FY2025, current liabilities decreased 20.2% year-over-year.
- Peak current liabilities was recorded in FY2019.
- Lowest current liabilities in the period was in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -3.49 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current LiabilitiesValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $11.9M | -20.2% |
| FY2024 | $15.0M | -28.8% |
| FY2022 | $21.0M | +84.0% |
| FY2021 | $11.4M | -57.1% |
| FY2020 | $26.6M | -49.5% |
| FY2019 | $52.8M | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026